Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11846943rdf:typepubmed:Citationlld:pubmed
pubmed-article:11846943lifeskim:mentionsumls-concept:C0037929lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0025815lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0027767lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0038954lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0036085lld:lifeskim
pubmed-article:11846943lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:11846943pubmed:issue6lld:pubmed
pubmed-article:11846943pubmed:dateCreated2002-2-15lld:pubmed
pubmed-article:11846943pubmed:abstractTextWe previously demonstrated that administration of 7.5% hypertonic saline (HS) significantly improved spinal cord blood flow and neurological outcomes after spinal cord injury. The aim of this study was to determine whether hypertonicity would enhance the effects of methylprednisolone (MP), further improving neurological function.lld:pubmed
pubmed-article:11846943pubmed:languageenglld:pubmed
pubmed-article:11846943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11846943pubmed:citationSubsetIMlld:pubmed
pubmed-article:11846943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11846943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11846943pubmed:statusMEDLINElld:pubmed
pubmed-article:11846943pubmed:monthDeclld:pubmed
pubmed-article:11846943pubmed:issn0148-396Xlld:pubmed
pubmed-article:11846943pubmed:authorpubmed-author:TumaR FRFlld:pubmed
pubmed-article:11846943pubmed:authorpubmed-author:YoungW FWFlld:pubmed
pubmed-article:11846943pubmed:authorpubmed-author:LegosJ JJJlld:pubmed
pubmed-article:11846943pubmed:authorpubmed-author:GritmanK RKRlld:pubmed
pubmed-article:11846943pubmed:issnTypePrintlld:pubmed
pubmed-article:11846943pubmed:volume49lld:pubmed
pubmed-article:11846943pubmed:ownerNLMlld:pubmed
pubmed-article:11846943pubmed:authorsCompleteYlld:pubmed
pubmed-article:11846943pubmed:pagination1427-33lld:pubmed
pubmed-article:11846943pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:meshHeadingpubmed-meshheading:11846943...lld:pubmed
pubmed-article:11846943pubmed:year2001lld:pubmed
pubmed-article:11846943pubmed:articleTitleCoadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury.lld:pubmed
pubmed-article:11846943pubmed:affiliationDepartment of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.lld:pubmed
pubmed-article:11846943pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11846943pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11846943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11846943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11846943lld:pubmed